Eliminates criminal and civil penalties for possession of controlled substances; establishes the drug decriminalization task force to develop recommendations for reforming state laws, regulations and practices so that they align with the stated goal of treating substance use disorder as a disease, rather than a criminal behavior.
S03600 would decriminalize simple possession of controlled substances in New York by changing Penal Law section 220.03 from a criminal misdemeanor offense to an unlawful possession violation punishable only by a fine of up to $50 or participation in a needs screening. The screening is designed to identify health and social service needs, including substance use treatment, mental health care, housing, employment, food, and civil legal services, and the fine would be waived if the screening is completed within 45 days. The bill also creates exceptions for residual drug amounts in syringes/needles and for possession discovered when a person seeks emergency medical help for an overdose or other life-threatening emergency.
The bill also expands record relief and post-conviction remedies. It adds controlled-substance possession under section 220.03 to sealing and expungement provisions, bars plea waivers of sealing eligibility for those offenses, and requires automatic vacatur, dismissal, and expungement of certain eligible convictions. It further amends post-conviction motion practice to make it easier to challenge certain drug convictions, including removing prejudice requirements in specified circumstances and strengthening presumptions tied to collateral consequences. In addition, it repeals two Penal Law provisions related to drug offenses and narrows the definition of drug-related paraphernalia by removing certain cocaine-specific language and excluding items used to inject, ingest, inhale, or otherwise introduce drugs into the body from the paraphernalia definition.
The bill would also create a temporary Drug Decriminalization Task Force within the Public Health Law. That task force would study evidence and recommend reforms to align state law with a public-health approach to substance use disorder, including identifying personal-use quantities, examining barriers to services, considering harm reduction, immigration consequences, family separation, civil collateral consequences, and racial disparities in enforcement, and proposing changes to the Penal Law, Social Services Law, and other statutes. The task force would include state agency officials, legislative appointees, and experts, as well as people directly affected by prior drug convictions and incarceration, and would issue a report and draft legislation within one year.
Overall sentiment in the bill text is strongly supportive of decriminalization and public-health-based responses to drug use. The findings section frames current drug criminalization as ineffective and harmful, emphasizing overdose risk, infectious disease, mass incarceration, family disruption, and disproportionate impacts on Black and Latinx communities. No committee transcript or vote history was provided, so there is no recorded legislative debate or voting pattern to gauge broader political support or opposition.
The main points of contention implied by the bill are the shift away from criminal penalties, the elimination of existing drug-possession offenses, and the broader record-expungement and post-conviction relief provisions. Potentially controversial elements include the removal of criminal sanctions for possession, the treatment of possession as a fine-only violation, the impact on policing and prosecution, and the task force’s mandate to consider decriminalizing or reworking related areas such as methadone and buprenorphine possession, immigration consequences, and racial disparities. Because no discussion transcript was provided, the specific supporters and opponents are not identified in the record here.
The bill would substantially amend the Penal Law, Criminal Procedure Law, General Business Law, and Public Health Law. It would replace the criminal offense of possession of a controlled substance in the seventh degree with a non-criminal violation, expand sealing and expungement eligibility for affected convictions, alter post-conviction motion standards, repeal two drug-related Penal Law sections, and revise the definition of drug-related paraphernalia. It would also create a temporary state task force to recommend broader drug policy reforms, affecting state agencies, courts, prosecutors, defense counsel, and people with current or past drug-possession cases.
The bill’s stated purpose and findings reflect a strongly reform-oriented, public-health-centered approach to drug policy. The text presents decriminalization as a life-saving measure intended to reduce harm, stigma, and racial disparities, and to improve access to treatment and services. No votes or committee transcripts were provided, so there is no documented legislative sentiment beyond the bill’s own framing.
The likely areas of contention are the elimination of criminal penalties for controlled-substance possession, the conversion of an existing misdemeanor into a fine-only violation, and the retroactive record-relief provisions. Opponents may focus on concerns about deterrence, enforcement, public safety, and the scope of automatic expungement and post-conviction relief, while supporters are likely to emphasize overdose prevention, treatment access, and reducing racial and collateral harms. The task force’s inclusion of harm reduction, immigration consequences, and decriminalization-related reforms may also be debated, but no transcript or vote record is available to identify specific positions.